mcm-hs_left-white_col_chse.png

©  2019 - McMaster University Update in Thromboembolism 

 

Privacy Policy |  McMaster CHSE Website

Download the McMaster CHSE Mobile APP

FOR MORE INFORMATION

Shawn Locke, CHSE Coordinator
McMaster University, Continuing Health Sciences Education
1280 Main St. W., DBHSC, Room 5004, Hamilton, ON L8S 4K1
P: 905-525-9140 ext. 21098
F: 905-572-7099
lockes1@mcmaster.ca

 

FOR REGISTRATION INFORMATION

P: 905-525-9140 ext. 22671

cmereg@mcmaster.ca

Learning Objectives

By attending this activity, participants will be able to: 

  • Discuss relevant and current evidence in the clinical management of anticoagulation in common thromboembolic disorders.

  • Manage non-lower extremity thrombosis regarding need for treatment and duration of anticoagulation.

  • Discuss thrombotic risk and management in special populations, including patients with cancer and sickle cell disease.

 
 
Presentation Specific Learning Objectives

 

What’s New in Thrombosis in 2019 - Eric Tseng

By attending this session, participants will be able to:

 

  • Describe recently published, practice-changing trials in thromboembolism 

                        

Prevention and Treatment of Cancer-Associated Thrombosis in 2019 - Peter Gross

By attending this session, participants will be able to:

            

  • Describe the results of recent trials evaluating use of direct oral anticoagulants to treat cancer associated thrombosis                     

  • Apply an approach to treatment of cancer associated thrombosis           

             

How I Manage Superficial Vein and Calf Vein Thrombosis - Lori Linkins

By attending this session, participants will be able to:

            

  • Apply an approach to management of superficial thrombophlebitis of the limb

  • Apply an approach to management of below-knee deep vein thrombosis            

             

How I Treat Upper Extremity DVT and Line-Associated DVT - Rick Ikesaka

By attending this session, participants will be able to:

            

  • Describe the risk factors and anticoagulant management of upper extremity DVT 

  • Discuss management of line-associated DVT      

             

Venous Thromboembolism associated with Myeloproliferative Neoplasms - Deb Siegal

By attending this session, participants will be able to:

 

  • Discuss how myeloproliferative neoplasms may be associated with thrombosis 

  • Describe management of thrombotic complications in patients with myeloproliferative neoplasms 

             

Oral Contraceptives and Risk of Venous Thromboembolism: A Practical Approach - Shannon Bates       

By attending this session, participants will be able to:

 

  • Apply outline of the thrombotic risk associated with oral contraceptives

  • Provide a practical approach to counselling and managing patients with venous thromboembolism         

             

Thrombophilia Testing: Laboratory Aspects and Drug Interactions - Karen Moffat

By attending this session, participants will be able to:

            

  • Understand Thrombophilia laboratory test principles with a focus on anticoagulant drug interferences and the impact on results                                               

  • Have knowledge of the Choosing Wisely thrombophilia testing recommendations as they relate to laboratory testing                                  

  • Understand The current laboratory guideline relating to measurement of DOACs

 

Highlights from the 2019 American Society of Hematology Thrombosis Guidelines: A focus on preventing VTE - Allison Burnett 

By attending this session, participants will be able to:

            

  • Appreciate VTE prophylaxis recommendations for hospitalized medical patients                                

  • Discuss VTE prophylaxis recommendations for patients discharged from the hospital after an acute medical illness                    

  • Describe which long-distance travelers may benefit from VTE prophylaxis                         

 

Venous Thromboembolism in Sickle Cell Disease - Rakhi Naik    

By attending this session, participants will be able to:

 

  • Review the pathophysiology of thrombosis associated with sickle cell disease 

  • Discuss management of venous thromboembolism in sickle cell disease